Haploidentical transplant with post-transplant cyclophosphamide for T-cell acute lymphoblastic leukemia: a report from the EBMT acute leukemia working party.

•Outcomes of 122 haploidentical hematopoietic cell transplantations with post-transplantation cyclophosphamide for T cell acute lymphoblastic leukemia are reported.•Survival was mostly affected by disease status, being significantly better in first complete remission•Outcomes were not affected by conditioning, calling into question the need for total body irradiation.